Cargando…

Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword

Coronavirus disease 2019, or COVID-19, is a major challenge facing scientists worldwide. Alongside the lungs, the system of organs comprising the GI tract is commonly targeted by COVID-19. The dysbiotic modulations in the intestine influence the disease severity, potentially due to the ability of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petakh, Pavlo, Kamyshna, Iryna, Nykyforuk, Andriy, Yao, Rouan, Imbery, John F., Oksenych, Valentyn, Korda, Mykhaylo, Kamyshnyi, Aleksandr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955861/ https://www.ncbi.nlm.nih.gov/pubmed/35336884 http://dx.doi.org/10.3390/v14030477

Ejemplares similares

Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
por: Petakh, Pavlo, et al.
Publicado: (2023)

Effects of metformin on the gut microbiota: A systematic review
por: Pavlo Petakh, et al.
Publicado: (2023)

Weil’s Disease—Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota
por: Petakh, Pavlo, et al.
Publicado: (2022)

The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
por: Petakh, Pavlo, et al.
Publicado: (2023)

Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review
por: Petakh, Pavlo, et al.
Publicado: (2023)

Tyrosine Kinase Inhibitors Target B Lymphocytes
por: Upfold, Nikki Lyn Esnardo, et al.
Publicado: (2023)

The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023)

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023)

Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023)

Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method
por: Petakh, Pavlo, et al.
Publicado: (2023)

Risks of outbreaks: The health concerns of internally displaced persons in Transcarpathia, Ukraine
por: Petakh, Pavlo, et al.
Publicado: (2023)

Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience
por: Kamyshnyi, Aleksandr, et al.
Publicado: (2023)

The Relationship between COVID-19 Severity in Children and Immunoregulatory Gene Polymorphism
por: Kozak, Kateryna, et al.
Publicado: (2023)

Almond Consumption and Inflammatory Biomarkers: A Need for Further Investigation
por: Petakh, Pavlo, et al.
Publicado: (2023)

Infectious diseases during the Russian-Ukrainian war - Morbidity in the Transcarpathian region as a marker of epidemic danger on the EU border
por: Petakh, Pavlo, et al.
Publicado: (2023)

Association of Myocardial Changes and Gene Expression of the NFATC1 and NFATC4—Calcineurin Signaling Pathway in Children with Bicuspid Aortic Valve
por: Kamenshchyk, Andrii, et al.
Publicado: (2023)

Association between NMDA gene polymorphism (rs4880213) and GRIN2B blood serum levels in thyroid pathology patients
por: Kamyshna, Iryna Ivanivna, et al.
Publicado: (2022)

Altered Blood Molecular Markers of Cardiovascular Function in Rats after Intrauterine Hypoxia and Drug Therapy
por: Popazova, Olena, et al.
Publicado: (2023)

Diet in Intestinal Fibrosis: A Double-Edged Sword
por: Marion-Letellier, Rachel, et al.
Publicado: (2021)

Double-edged sword.
Publicado: (1994)

Cardioprotective Activity of Pharmacological Agents Affecting NO Production and Bioavailability in the Early Postnatal Period after Intrauterine Hypoxia in Rats
por: Popazova, Olena, et al.
Publicado: (2023)

25-OH Vitamin D blood serum linkage with VDR gene polymorphism (rs2228570) in thyroid pathology patients in the West-Ukrainian population
por: Kamyshna, Iryna Ivanivna, et al.
Publicado: (2021)

Analysis of the transcriptional activity of genes of neuropeptides and their receptors in the blood of patients with thyroid pathology
por: Kamyshna, Iryna Ivanivna, et al.
Publicado: (2021)

The microbiota and chronic kidney diseases: a double-edged sword
por: Felizardo, Raphael Jose Ferreira, et al.
Publicado: (2016)

The double-edged sword of evolution
por: Kruzel-Davila, Etty, et al.
Publicado: (2017)

A double-edged sword
por: Vandebotermet, Martijn, et al.
Publicado: (2020)

Microbiota and Graft-versus Host disease: a double-edged sword
por: Holler, Ernst, et al.
Publicado: (2019)

Seatbelt: A Double-Edged Sword
por: Raychaudhuri, P., et al.
Publicado: (2012)

The double-edged sword of fibronectin in atherosclerosis
por: Moore, Kathryn J, et al.
Publicado: (2012)

ATT- A Double Edged Sword?
por: Gude, D., et al.
Publicado: (2011)

Leukocytes: The Double-Edged Sword in Fibrosis
por: Kryczka, Jakub, et al.
Publicado: (2015)

Apoptosis, A Double-Edge Sword!
por: Rossello, Xavier, et al.
Publicado: (2017)

Doubled-Edged Swords in the Biology of Conflict
por: Sapolsky, Robert M.
Publicado: (2018)

Immunity to PRRSV: Double-edged sword
por: Molitor, T.W., et al.
Publicado: (1997)

Warfarin: A double-edged sword
por: Yadav, Prabhakar, et al.
Publicado: (2019)

MAVS is a double-edged sword
por: Huang, Christina, et al.
Publicado: (2023)

Gut microbiota status in leptospirosis: An unrecognized player?
por: Petakh, Pavlo, et al.
Publicado: (2022)

Active Components of Commonly Prescribed Medicines Affect Influenza A Virus–Host Cell Interaction: A Pilot Study
por: Ianevski, Aleksandr, et al.
Publicado: (2021)

The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

At War Within: The Double-Edged Sword of Immunity
por: Edgar, D
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_rh6j4bsoge8q9pfs0p9f14kv50